跳至主要内容
临床试验/KCT0003487
KCT0003487招募中未知

ong-term Safety of Entecavir and Tenofovir in Patients with Treatment-naïve Chronic Hepatitis B Virus (CHB) Infection (SAINT study) in real life setting

Hanyang University Seoul Hospital0 个研究点目标入组 2,000 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
2,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. Patients aged 18 or older with CHB
  • 2. Patients with treatment-naïve chronic hepatitis B virus (CHB) infection between 2012 and 2015 in the applicable hospital
  • (including interferon-based treatment or oral antiviral agents within 3 months due to acute hepatitis B exacerbation)
  • 3. Patients with antiviral treatment for 6 months or over

排除标准

  • 1. Patients with no initial treatment between 2012 and 2015 in the hospital
  • 2. Patients who have taken antiviral agents in another hospital
  • 3. Patients with chronic hepatitis C, HIV and coinfection
  • 4. Patients with history of hepatocellular carcinoma
  • 5. Patients diagnosed with malignant tumor(except hematologic malignancy) within 5 years prior to antiviral treatment
  • 6. Patient with insufficient data

研究者

发起方
Hanyang University Seoul Hospital

相似试验